Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice Guideline
Christopher E. Desch(American Society of Clinical Oncology), Nicholas J. Petrelli(Christiana Care Health System), Patrick J. Flynn(American Society of Clinical Oncology), Al B. Benson(Northwestern University), Katherine S. Virgo(Emory University), Mark R. Somerfield(American Society of Clinical Oncology), Bruce D. Minsky(The University of Texas MD Anderson Cancer Center), David G. Pfister(Memorial Sloan Kettering Cancer Center), Carol Krause(American Society of Clinical Oncology), Charles L. Loprinzi(Mayo Clinic in Arizona)
Cited by 565
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
|Journal of Clinical Oncology|2004|2.4k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer
|Journal of Clinical Oncology|2004|1.5k